Researchers confirmed the long-term safety profile of ozanimod for the treatment of moderate to severe UC or RMS.

Mental health comorbidities are more prevalent among transgender and gender nonconforming adults with IBD than the general and IBD US populations.

Risankizumab for Crohn disease taken over a long-term extension results in clinically meaningful sustained HRQOL improvements.

Ileosigmoid fistulas in Crohn disease are surgically managed in varying ways, which suggests a need for standardized guidelines.

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

Overall survival at 5 years for individuals who received a liver transplant for certain cancers is deemed adequate.

During pregnancy, women should receive recommended COVID-19 vaccines to protect themselves, as well as their young infants.

Acute pancreatitis severity, in addition to subcutaneous fat area and baseline C-reactive protein, can help predict diabetes in youth.

Casirivimab and imdevimab in combination is safe among pediatric outpatients with at least 1 risk factor for severe COVID-19.

The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist obesity medications.

An algorithm can identify individuals with MASLD with 88 percent accuracy using electronic medical record (EMR) data.

Palliative care is associated with a reduction in inpatient procedures in terminal hospitalizations for patients with hepatocellular carcinoma (HCC), according to study results published in the ...